For: | Qiu FN, Huang Y, Chen DY, Li F, Wu YA, Wu WB, Huang XL. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World J Gastroenterol 2016; 22(16): 4226-4237 [PMID: 27122673 DOI: 10.3748/wjg.v22.i16.4226] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i16/4226.htm |
Number | Citing Articles |
1 |
Wenya Bai, Siying Huo, Guilin Zhou, Junjie Li, Yuan Yang, Jianlin Shao. Biliverdin modulates the Nrf2/A20/eEF1A2 axis to alleviate cerebral ischemia-reperfusion injury by inhibiting pyroptosis. Biomedicine & Pharmacotherapy 2023; 165: 115057 doi: 10.1016/j.biopha.2023.115057
|
2 |
Saket Awadhesbhai Patel, Md. Khurshidul Hassan, Manjusha Dixit. Oncogenic activation of EEF1A2 expression: a journey from a putative to an established oncogene. Cellular & Molecular Biology Letters 2024; 29(1) doi: 10.1186/s11658-023-00519-9
|
3 |
Jianxin Hu, Heng Luo, Yuangao Xu, Guangheng Luo, Shuxiong Xu, Jianguo Zhu, Dalong Song, Zhaolin Sun, Youlin Kuang. The Prognostic Significance of EIF3C Gene during the Tumorigenesis of Prostate Cancer. Cancer Investigation 2019; 37(4-5): 199 doi: 10.1080/07357907.2019.1618322
|
4 |
Peerut Chienwichai, Supachai Topanurak, Onrapak Reamtong, Usa Boonyuen, Suwalee Worakhunpiset, Prapin Tharnpoophasiam. Effects of low bisphenol A concentration on protein expression profiles in an in vitro model of non-alcoholic fatty liver disease. Molecular & Cellular Toxicology 2018; 14(1): 61 doi: 10.1007/s13273-018-0008-2
|
5 |
Juncai Liu, Hongjing Zhu. TMEM106A inhibits cell proliferation, migration, and induces apoptosis of lung cancer cells. Journal of Cellular Biochemistry 2019; 120(5): 7825 doi: 10.1002/jcb.28057
|
6 |
Weicheng Zhang, Jiyan Wang, Changliang Shan. The eEF1A protein in cancer: Clinical significance, oncogenic mechanisms, and targeted therapeutic strategies. Pharmacological Research 2024; 204: 107195 doi: 10.1016/j.phrs.2024.107195
|
7 |
Md. Khurshidul Hassan, Dinesh Kumar, Monali Naik, Manjusha Dixit, Aamir Ahmad. The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers. PLOS ONE 2018; 13(1): e0191377 doi: 10.1371/journal.pone.0191377
|
8 |
Kawinthra Khwanraj, Athinan Prommahom, Permphan Dharmasaroja, Swapan Ray. eEF1A2 siRNA Suppresses MPP+-Induced Activation of Akt and mTOR and Potentiates Caspase-3 Activation in a Parkinson’s Disease Model. The Scientific World Journal 2023; 2023: 1 doi: 10.1155/2023/1335201
|
9 |
O. V. Novosylna. Protein isoforms. Origin, structure and functions.. Biopolymers and Cell 2017; 33(3): 161 doi: 10.7124/bc.00094E
|
10 |
Francesca Perrone, Emanuela Fabiola Craparo, Maja Cemazar, Urska Kamensek, Salvatore Emanuele Drago, Barbara Dapas, Bruna Scaggiante, Fabrizio Zanconati, Debora Bonazza, Mario Grassi, Nhung Truong, Gabriele Pozzato, Rossella Farra, Gennara Cavallaro, Gabriele Grassi. Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer. Journal of Controlled Release 2021; 330: 1132 doi: 10.1016/j.jconrel.2020.11.020
|
11 |
Ning Ma, Tian Zhou, Chunyu Li, Xue Luo, Song Chen, Xue-yin Zhu, Xing-hong Chen, Haoxi Liu, Hai-ying Tian, Qing-jun Gao, Dai-wei Zhao. A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma. Heliyon 2024; 10(3): e24455 doi: 10.1016/j.heliyon.2024.e24455
|
12 |
Lei Xia, Hui Wang, He Xiao, Baohua Lan, Jie Liu, Zhenzhou Yang. EEF1A2 and ERN2 could potentially discriminate metastatic status of mediastinal lymph node in lung adenocarcinomas harboring EGFR 19Del/L858R mutations. Thoracic Cancer 2020; 11(10): 2755 doi: 10.1111/1759-7714.13554
|
13 |
Han Zhang, Fei Xie, Xiao-ya Yuan, Xin-tong Dai, Yun-feng Tian, Ming-ming Sun, Si-qi Yu, Jia-you Cai, Bin Sun, Wei-cheng Zhang, Chang-liang Shan. Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1. Acta Pharmacologica Sinica 2024; 45(5): 1044 doi: 10.1038/s41401-024-01231-w
|
14 |
Md. Khurshidul Hassan, Dinesh Kumar, Saket Awadhesbhai Patel, Niharika Pattanaik, Nachiketa Mohapatra, Manjusha Dixit. Expression pattern of EEF1A2 in brain tumors: Histological analysis and functional role as a promoter of EMT. Life Sciences 2020; 246: 117399 doi: 10.1016/j.lfs.2020.117399
|
15 |
Rossella Farra, Bruna Scaggiante, Chiara Guerra, Gabriele Pozzato, Mario Grassi, Fabrizio Zanconati, Francesca Perrone, Cinzia Ferrari, Francesco Trotta, Gabriele Grassi, Barbara Dapas. Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs. International Journal of Pharmaceutics 2017; 525(2): 367 doi: 10.1016/j.ijpharm.2017.02.031
|
16 |
Rossella Farra, Francesco Musiani, Francesca Perrone, Maja Čemažar, Urška Kamenšek, Federica Tonon, Michela Abrami, Aleš Ručigaj, Mario Grassi, Gabriele Pozzato, Deborah Bonazza, Fabrizio Zanconati, Giancarlo Forte, Maguie El Boustani, Lucia Scarabel, Marica Garziera, Concetta Russo Spena, Lucia De Stefano, Barbara Salis, Giuseppe Toffoli, Flavio Rizzolio, Gabriele Grassi, Barbara Dapas. Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness. Molecules 2018; 23(4): 777 doi: 10.3390/molecules23040777
|
17 |
Mariko Yamato, Tomoko Dai, Yoshihiko Murata, Tomoki Nakagawa, Shinji Kikuchi, Daisuke Matsubara, Masayuki Noguchi. High expression of eukaryotic elongation factor 1‐alpha‐2 in lung adenocarcinoma is associated with poor prognosis. Pathology International 2024; 74(8): 454 doi: 10.1111/pin.13457
|
18 |
Jian Zhang, Huiwen Wang, Qianbing Wang, Juan Mo, Lei Fu, Shifang Peng. EEF1A2 identified as a hub gene associated with the severity of metabolic dysfunction-associated steatotic liver disease. Mammalian Genome 2024; doi: 10.1007/s00335-024-10078-9
|
19 |
Wanying Kang, Chen Ye, Yunyun Yang, Yan-Ru Lou, Mingyi Zhao, Zhuo Wang, Yuan Gao. Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1383304
|
20 |
Wen‑Ya Pan, Jiang‑Hui Zeng, Dong‑Yue Wen, Jie‑Yu Wang, Peng‑Peng Wang, Gang Chen, Zhen‑Bo Feng. Oncogenic value of microRNA‑15b‑5p in hepatocellular carcinoma and a bioinformatics investigation. Oncology Letters 2018; doi: 10.3892/ol.2018.9748
|
21 |
Burcu Biterge-Sut. Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation. Life Sciences 2019; 238: 116977 doi: 10.1016/j.lfs.2019.116977
|
22 |
Yingsheng Wu, Dongkai Zhou, Xiaobo Xu, Xinyi Zhao, Pengfei Huang, Xiaohu Zhou, Wei Song, Hua Guo, Weilin Wang, Shusen Zheng. Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0922-5
|
23 |
Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante, Aamir Ahmad. Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis. PLOS ONE 2019; 14(6): e0218030 doi: 10.1371/journal.pone.0218030
|
24 |
Amal Ahmed, Noha Nagah, Noha Osama, Wael Hafez, Ali Elsaid Abdelrahman Ali, Mahmoud Maamoun Shaheen, Ayman Abd Alhady Alkhalegy, Eman Alsayed Abouahmed, Shamel Mohamed Soaida, Lamees.A. Samy, Ahmed El-Kasses, Ivan Cherrez Ojeda, Rehab Refaat. Expression of miR-15b-5p and Toll-like receptor-4 as potential novel diagnostic biomarkers for Hepatitis C virus- induced hepatocellular carcinoma. Non-coding RNA Research 2024; doi: 10.1016/j.ncrna.2024.12.003
|